are they stopping semaglutide What happens when patients stop taking GLP-1 drugs? New study reveals real world insights Semaglutide Discontinuation and Its Health

Summary: Retatrutide is an investigational triple incretin receptor agonist not licensed in the UK and not supported by clinical evidence for muscle growth

Similar theoretical trajectories may occur during GLP-1 RA therapy, particularly when expectations remain unmet or psychological adjustment to physical change is limited

GLP-1 stands for Glucagon-Like Peptide-1, a naturally occurring incretin hormone produced in the small intestine that regulates blood glucose levels and appetite

Cell 155 , 16241638 (2013)

Practical protocols and real-world considerations Clinical trial data is generated under controlled conditions with careful patient selection, regular monitoring, and professional oversight